Press Releases

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.

Neuland to open commercial peptide facility as part of planned phased expansion

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Verista Delivers Comprehensive CSV Services to Ensure Regulatory Compliance and Data Integrity Across the Life Sciences Industry

Services provide expert-led validation, ensuring compliance, efficiency, and data integrity across systems.

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility. The submission follows the successful execution of multiple aseptic process simulations (APS media-fill batches), completed in accordance with the revised EU GMP Annex 1 (2023) requirements.

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Ardena Appoints Paul Edwards as Chief People Officer

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley

START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions.

Symbiosis Appoints Joanne Anderson as Chief Commercial Officer

Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board

• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively

Epigenica AB Launches EpiFinder™ cNUC: The First Platform to Simultaneously Profile Multiple Histone Marks and DNA Methylation Directly from Circulating Nucleosomes in Plasma and Serum

Epigenica has announced the launch of EpiFinder™ cNUC, a unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes.

Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board

Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

ClearNote Health announced an enhanced Avantect® Pancreatic Cancer Test, which delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5% for patients at elevated risk of this disease.

Amorphical to Present Long-Term Phase 2 Crohn’s Disease Data at the 21st Congress of ECCO

Pumas 2.8 Sets a New Standard for Clinical Pharmacology and Pharmacometrics Technology with Embedded AI and Next Generation Estimation

Sygnature Discovery Unveils Strategic Rebrand to Cement Status as a Global Drug Discovery Partner

GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services company, have signed a Memorandum of Understanding (MOU) to collaborate on multinational clinical trial services.